Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Medtronic (Magellan Platelet Business)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer of medical device that delivers concentrated platelets for surgical wound healing. The Magellan System, is a one-source biologic concentrator and delivery system that collects and concentrates platelets and white blood cells from a small volume of a patient's own blood, providing a readily accessible supply of plasma that serves as a foundation for autologous platelet gel.

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 11000 Cedar Avenue
  • Suite 270
  • Cleveland, OH 44106
  • United States

+1 (216) 000-0000

Medtronic (Magellan Platelet Business) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Medtronic (Magellan Platelet Business)‘s full profile, request access.

Request full access to PitchBook

Medtronic (Magellan Platelet Business) Executive Team (2)

Name Title Board
Seat
Contact
Info
Donald Brown Chief Executive Officer
Scott Ward President & Senior Vice President, Vascular